Home » FDA Grants Orphan Drug Status to Treatment for Joint Condition
FDA Grants Orphan Drug Status to Treatment for Joint Condition
A treatment under development by BioMimetic Therapeutics for a painful joint condition has received orphan drug status from the FDA, the company said Thursday.
CB Online
CB Online
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May